AKT1 and diabetic kidney disease: Similarity, Huang et al. created a rat model of DKD by intraperitoneal injections of STZ at a dosage of 65 mg/kg and found that the protein expression levels of p-PI3K and p-Akt were notably reduced in the kidneys (Huang et al., 2016).